This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy?

Stanley Druckenmiller's Duquesne family office has maintained Natera as its largest holding for 8 consecutive quarters. The medical diagnostics company uses liquid biopsy technology for cancer detection and other applications, showing strong growth with 57% year-over-year increase in oncology tests and 38% revenue growth. Despite persistent losses, the company has strong cash reserves and is projected to approach profitability by 2027. However, the stock has surged 87% in the past year with a lofty price-to-sales ratio of 17.